Valeant Pharmaceuticals International Inc (NYSE:VRX)

202.66
BATS BZX Real-Time Price
As of 3:48pm ET
 -0.69 / -0.34%
Today’s Change
106.00
Today|||52-Week Range
204.66
+41.61%
Year-to-Date

Stock Price Forecast

The 20 analysts offering 12-month price forecasts for Valeant Pharmaceuticals have a median target of 220.00, with a high estimate of 242.00 and a low estimate of 141.00. The median estimate represents a +8.56% increase from the last price of 202.66.

Analyst Recommendations

The current consensus among 21 polled investment analysts is to Buy stock in Valeant Pharmaceuticals. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$2.31
Sales
$2.1B
Reporting Date
Apr 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -10.53%
 
 
 
 
 
 
Growthannually 25.40%
 
 
 
 
 
 

Sales

Growthquarterly -5.81%
 
 
 
 
 
 
Growthannually 15.65%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account